Cardiff Oncology Inc

NASDAQ: CRDF
$4.36
-$0.10 (-2.2%)
Closing price April 30, 2024
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California.
24/7 Wall St. tracked six new secondary offerings that were announced after the close on Tuesday, September 29, 2020.